Stage-dependent biomarker changes in spinocerebellar ataxia type 3
View ORCID ProfileJennifer Faber, View ORCID ProfileMoritz Berger, View ORCID ProfileWilke Carlo, View ORCID ProfileJeannette Hübener-Schmid, Tamara Schaprian, View ORCID ProfileMagda M Santana, Marcus Grobe-Einsler, Dement Onder, Berkan Koyak, View ORCID ProfilePaola Giunti, Hector Garcia-Moreno, Cristina Gonzalez-Robles, View ORCID ProfileManuela Lima, View ORCID ProfileMafalda Raposo, Ana Rosa Vieira Melo, Luís Pereira de Almeida, Patrick Silva, Maria M Pinto, View ORCID ProfileBart P. van de Warrenburg, Judith van Gaalen, Jeroen Jeroen de Vries, View ORCID ProfileGulin Oz, View ORCID ProfileJames M. Joers, View ORCID ProfileMatthis Synofzik, Ludger Schöls, Olaf Riess, View ORCID ProfileJon Infante, Leire Manrique, View ORCID ProfileDagmar Timmann, View ORCID ProfileAndreas Thieme, View ORCID ProfileHeike Jacobi, View ORCID ProfileKathrin Reetz, View ORCID ProfileImis Dogan, View ORCID ProfileChiadikaobi Onyike, View ORCID ProfileMichal Povazan, View ORCID ProfileJeremy Schmahmann, View ORCID ProfileEva-Maria Ratai, View ORCID ProfileMatthias Schmid, View ORCID ProfileThomas Klockgether
doi: https://doi.org/10.1101/2023.04.21.23287817
Jennifer Faber
1German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
2Department of Neurology, University Hospital Bonn, Bonn, Germany
Moritz Berger
3University of Bonn, Medical Faculty, Institute for Medical Biometry, Informatics and Epidemiology
Wilke Carlo
4Division Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, Germany
5German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
Jeannette Hübener-Schmid
6Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany
Tamara Schaprian
1German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
Magda M Santana
7Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal
8Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal
Marcus Grobe-Einsler
1German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
2Department of Neurology, University Hospital Bonn, Bonn, Germany
Dement Onder
1German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
2Department of Neurology, University Hospital Bonn, Bonn, Germany
Berkan Koyak
1German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
2Department of Neurology, University Hospital Bonn, Bonn, Germany
Paola Giunti
9Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK
10Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London WC1N 3BG, UK
Hector Garcia-Moreno
9Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK
10Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London WC1N 3BG, UK
Cristina Gonzalez-Robles
9Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK
10Department of Neurogenetics, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London WC1N 3BG, UK
11Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK
Manuela Lima
12Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal
Mafalda Raposo
12Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal
13Instituto de Biologia Molecular e Celular (IBMC), Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal
Ana Rosa Vieira Melo
12Faculdade de Ciências e Tecnologia, Universidade dos Açores, Ponta Delgada, Portugal
Luís Pereira de Almeida
7Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal
8Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal
Patrick Silva
7Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal
8Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal
14Faculty of Pharmacy, University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
Maria M Pinto
7Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal
8Center for Innovative in Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal
14Faculty of Pharmacy, University of Coimbra, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
Bart P. van de Warrenburg
15Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud university medical center
Judith van Gaalen
15Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud university medical center
16Department of Neurology, Rinjstate Hospital, Arnhem, The Netherlands
Jeroen Jeroen de Vries
17University Medical Center Groningen, Neurology
Gulin Oz
18Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA
James M. Joers
18Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA
Matthis Synofzik
4Division Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, Germany
5German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
Ludger Schöls
4Division Translational Genomics of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research & Center of Neurology, University of Tübingen, Germany
5German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
Olaf Riess
6Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany
Jon Infante
19University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain
20Centro de investigación biomédica en red de enfermedades neurodegenerativas (CIBERNED), Universidad de Cantabria, Santander, Spain
Leire Manrique
19University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain
Dagmar Timmann
21Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C- TNBS), University Hospital Essen, University of Duisburg-Essen
Andreas Thieme
21Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C- TNBS), University Hospital Essen, University of Duisburg-Essen
Heike Jacobi
22Department of Neurology, University Hospital of Heidelberg, Germany
Kathrin Reetz
23Department of Neurology, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
24JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Research Centre Juelich GmbH and RWTH Aachen University, 52074 Aachen, Germany
Imis Dogan
23Department of Neurology, RWTH Aachen University, Pauwelsstr. 30, 52074 Aachen, Germany
24JARA-BRAIN Institute Molecular Neuroscience and Neuroimaging, Research Centre Juelich GmbH and RWTH Aachen University, 52074 Aachen, Germany
Chiadikaobi Onyike
25Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland USA
Michal Povazan
26Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
Jeremy Schmahmann
27Ataxia Center, Laboratory for Neuroanatomy and Cerebellar Neurobiology, Massachusetts General Hospital and Harvard Medical School
Eva-Maria Ratai
28Massachusetts General Hospital, Department of Radiology, A. A. Martinos Center for Biomedical Imaging and Harvard Medical School, Charlestown, Massachusetts, USA
Matthias Schmid
1German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
3University of Bonn, Medical Faculty, Institute for Medical Biometry, Informatics and Epidemiology
Thomas Klockgether
1German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
2Department of Neurology, University Hospital Bonn, Bonn, Germany
Data Availability
Due to the sensitive nature of the data on rare diseases, access to the data can only be granted upon reasonable request, subject to the General Data Protection Regulation (GDPR) and any other relevant data protection laws. Please contact Jennifer Faber and Thomas Klockgether (jennifer.faber{at}dzne.de, thomas.klockgether{at}ukbonn.de) to submit a data access request.
Posted April 25, 2023.
Stage-dependent biomarker changes in spinocerebellar ataxia type 3
Jennifer Faber, Moritz Berger, Wilke Carlo, Jeannette Hübener-Schmid, Tamara Schaprian, Magda M Santana, Marcus Grobe-Einsler, Dement Onder, Berkan Koyak, Paola Giunti, Hector Garcia-Moreno, Cristina Gonzalez-Robles, Manuela Lima, Mafalda Raposo, Ana Rosa Vieira Melo, Luís Pereira de Almeida, Patrick Silva, Maria M Pinto, Bart P. van de Warrenburg, Judith van Gaalen, Jeroen Jeroen de Vries, Gulin Oz, James M. Joers, Matthis Synofzik, Ludger Schöls, Olaf Riess, Jon Infante, Leire Manrique, Dagmar Timmann, Andreas Thieme, Heike Jacobi, Kathrin Reetz, Imis Dogan, Chiadikaobi Onyike, Michal Povazan, Jeremy Schmahmann, Eva-Maria Ratai, Matthias Schmid, Thomas Klockgether
medRxiv 2023.04.21.23287817; doi: https://doi.org/10.1101/2023.04.21.23287817
Stage-dependent biomarker changes in spinocerebellar ataxia type 3
Jennifer Faber, Moritz Berger, Wilke Carlo, Jeannette Hübener-Schmid, Tamara Schaprian, Magda M Santana, Marcus Grobe-Einsler, Dement Onder, Berkan Koyak, Paola Giunti, Hector Garcia-Moreno, Cristina Gonzalez-Robles, Manuela Lima, Mafalda Raposo, Ana Rosa Vieira Melo, Luís Pereira de Almeida, Patrick Silva, Maria M Pinto, Bart P. van de Warrenburg, Judith van Gaalen, Jeroen Jeroen de Vries, Gulin Oz, James M. Joers, Matthis Synofzik, Ludger Schöls, Olaf Riess, Jon Infante, Leire Manrique, Dagmar Timmann, Andreas Thieme, Heike Jacobi, Kathrin Reetz, Imis Dogan, Chiadikaobi Onyike, Michal Povazan, Jeremy Schmahmann, Eva-Maria Ratai, Matthias Schmid, Thomas Klockgether
medRxiv 2023.04.21.23287817; doi: https://doi.org/10.1101/2023.04.21.23287817
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)